Skip to main content
SpringerLink
Log in

Severe Asthma in Pregnancy: Special Considerations

  • Chapter
  • First Online:
Difficult To Treat Asthma

Part of the book series: Respiratory Medicine ((RM))

  • 1118 Accesses

Abstract

Asthma is one of the most common conditions that afflict pregnant women. Because uncontrolled asthma in pregnancy affects both maternal and offspring outcomes, careful attention to maintaining control of asthma symptoms throughout pregnancy is of paramount importance. This chapter will review the epidemiology and course of asthma in pregnancy and the effects of uncontrolled asthma to both the mother and offspring and provide an overview of the management, both non-pharmacologic and pharmacologic, of asthma in pregnancy. While the management of asthma in pregnancy relies on guidelines for the general population, special considerations regarding the safety of medications are required. Data available for established medications and newer therapies are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mazurek JM, Syamlal G. Prevalence of asthma, asthma attacks, and emergency department visits for asthma among working adults – National Health Interview Survey, 2011–2016. MMWR Morb Mortal Wkly Rep. 2018;67(13):377–86.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol. 2003;13(5):317–24.

    Article  PubMed  Google Scholar 

  3. Hansen C, et al. Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Matern Child Health J. 2013;17(9):1611–21.

    Article  PubMed  Google Scholar 

  4. Kemppainen M, et al. Maternal asthma is associated with increased risk of perinatal mortality. PLoS One. 2018;13(5):e0197593.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Lee CH, et al. Healthcare utilisation by pregnant patients with asthma in South Korea: a cohort study using nationwide claims data. BMJ Open. 2015;5(11):e008416.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cleary BJ, et al. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19(4):408–17.

    PubMed  Google Scholar 

  7. Sawicki E, et al. Management of asthma by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol. 2012a;52(2):183–8.

    Article  PubMed  Google Scholar 

  8. Rejno G, et al. Asthma during pregnancy in a population-based study–pregnancy complications and adverse perinatal outcomes. PLoS One. 2014;9(8):e104755.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Schatz M, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol. 2004a;113(6):1040–5.

    Article  PubMed  Google Scholar 

  10. Blais L, et al. Long-acting beta(2)-agonists and risk of hypertensive disorders of pregnancy: a cohort study. J Allergy Clin Immunol Pract. 2018;6(2):555.

    Article  PubMed  Google Scholar 

  11. Gluck JC, Gluck P. The effects of pregnancy on asthma: a prospective study. Ann Allergy. 1976;37(3):164–8.

    CAS  PubMed  Google Scholar 

  12. Belanger K, et al. Effect of pregnancy on maternal asthma symptoms and medication use. Obstet Gynecol. 2010;115(3):559–67.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Schatz M, et al. The relationship of asthma-specific quality of life during pregnancy to subsequent asthma and perinatal morbidity. J Asthma. 2010;47(1):46–50.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Schatz M, et al. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol. 2003;112(2):283–8.

    Article  PubMed  Google Scholar 

  15. Stenius-Aarniala B, Piirila P, Teramo K. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax. 1988;43(1):12–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. White RJ, et al. A prospective study of asthma during pregnancy and the puerperium. Respir Med. 1989;83(2):103–6.

    Article  CAS  PubMed  Google Scholar 

  17. Beecroft N, Cochrane GM, Milburn HJ. Effect of sex of fetus on asthma during pregnancy: blind prospective study. BMJ. 1998;317(7162):856–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Henderson CE, et al. Predicting asthma severity from allergic sensitivity to cockroaches in pregnant inner city women. J Reprod Med. 2000;45(4):341–4.

    CAS  PubMed  Google Scholar 

  19. Kircher S, Schatz M, Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol. 2002;89(5):463–6.

    Article  PubMed  Google Scholar 

  20. Mirzakhani H, et al. Asthma control status in pregnancy, body mass index, and maternal vitamin D levels. J Allergy Clin Immunol. 2017;140(5):1453–1456 e7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Bobrowski RA. Pulmonary physiology in pregnancy. Clin Obstet Gynecol. 2010;53(2):285–300.

    Article  PubMed  Google Scholar 

  22. Hegewald MJ, Crapo RO. Respiratory physiology in pregnancy. Clin Chest Med. 2011;32(1):1–13.

    Article  PubMed  Google Scholar 

  23. LoMauro A, Aliverti A. Respiratory physiology of pregnancy: physiology masterclass. Breathe (Sheff). 2015;11(4):297–301.

    Article  Google Scholar 

  24. Wise RA, Polito AJ, Krishnan V. Respiratory physiologic changes in pregnancy. Immunol Allergy Clin N Am. 2006;26(1):1–12.

    Article  Google Scholar 

  25. Cooper BG. An update on contraindications for lung function testing. Thorax. 2011;66(8):714–23.

    Article  PubMed  Google Scholar 

  26. Choi HS, et al. Dyspnea and palpitation during pregnancy. Korean J Intern Med. 2001;16(4):247–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Milne JA. Respiratory response to pregnancy. Postgrad Med J. 1979;55(643):318–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wang G, et al. The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2014;27(9):934–42.

    Article  PubMed  Google Scholar 

  29. Mendola P, et al. Obstetric complications among US women with asthma. Am J Obstet Gynecol. 2013;208(2):127.e1–8.

    Article  Google Scholar 

  30. Murphy VE, et al. A prospective study of respiratory viral infection in pregnant women with and without asthma. Chest. 2013a;144(2):420–7.

    Article  PubMed  Google Scholar 

  31. Murphy VE, et al. A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG. 2011;118(11):1314–23.

    Article  CAS  PubMed  Google Scholar 

  32. Chen J, et al. In utero beta-2-adrenergic agonists exposure and risk of epilepsy: a Danish nationwide population-based cohort study. Pharmacoepidemiol Drug Saf. 2018;27(11):1200–8.

    Article  CAS  PubMed  Google Scholar 

  33. Eltonsy S, Forget A, Blais L. Beta2-agonists use during pregnancy and the risk of congenital malformations. Birth Defects Res A Clin Mol Teratol. 2011;91(11):937–47.

    Article  CAS  PubMed  Google Scholar 

  34. Litonjua AA, et al. Parental history and the risk for childhood asthma. Does mother confer more risk than father? Am J Respir Crit Care Med. 1998;158(1):176–81.

    Article  CAS  PubMed  Google Scholar 

  35. Liu X, et al. Maternal asthma severity and control during pregnancy and risk of offspring asthma. J Allergy Clin Immunol. 2018;141(3):886–92.e3.

    Article  PubMed  Google Scholar 

  36. Dombrowski MP, Schatz M, ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol. 2008;111(2 Pt 1):457–64.

    PubMed  Google Scholar 

  37. Schatz M, Dombrowski MP. Clinical practice. Asthma in pregnancy. N Engl J Med. 2009;360(18):1862–9.

    Article  CAS  PubMed  Google Scholar 

  38. Powell H, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet. 2011;378(9795):983–90.

    Article  CAS  PubMed  Google Scholar 

  39. Morten M, et al. Managing Asthma in Pregnancy (MAP) trial: FENO levels and childhood asthma. J Allergy Clin Immunol. 2018;142(6):1765–72.e4.

    Article  PubMed  Google Scholar 

  40. Koo SM, et al. Effect of pregnancy on quantitative medication use and relation to exacerbations in asthma. Biomed Res Int. 2017;2017:8276190.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Lim AS, et al. Asthma during pregnancy: the experiences, concerns and views of pregnant women with asthma. J Asthma. 2012;49(5):474–9.

    Article  PubMed  Google Scholar 

  42. Murphy VE, et al. Severe asthma exacerbations during pregnancy. Obstet Gynecol. 2005;106(5 Pt 1):1046–54.

    Article  PubMed  Google Scholar 

  43. Schatz M, Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol. 2005;95(3):234–8.

    Article  PubMed  Google Scholar 

  44. Lim AS, et al. Management of asthma in pregnant women by general practitioners: a cross sectional survey. BMC Fam Pract. 2011;12:121.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Lim AS, et al. Multidisciplinary approach to Management of Maternal Asthma (MAMMA): a randomized controlled trial. Chest. 2014;145(5):1046–54.

    Article  PubMed  Google Scholar 

  46. Ali Z, Nilas L, Ulrik CS. Excessive gestational weight gain in first trimester is a risk factor for exacerbation of asthma during pregnancy: a prospective study of 1283 pregnancies. J Allergy Clin Immunol. 2018;141(2):761–7.

    Article  PubMed  Google Scholar 

  47. Murphy VE, et al. Influence of maternal body mass index and macrophage activation on asthma exacerbations in pregnancy. J Allergy Clin Immunol Pract. 2017;5(4):981–987 e1.

    Article  PubMed  Google Scholar 

  48. Buczko GB, et al. Effects of cigarette smoking and short-term smoking cessation on airway responsiveness to inhaled methacholine. Am Rev Respir Dis. 1984;129(1):12–4.

    CAS  PubMed  Google Scholar 

  49. Mullen JB, et al. Nonspecific airway reactivity in cigarette smokers. Relationship to airway pathology and baseline lung function. Am Rev Respir Dis. 1986;133(1):120–5.

    Article  CAS  PubMed  Google Scholar 

  50. Murphy VE, Clifton VL, Gibson PG. The effect of cigarette smoking on asthma control during exacerbations in pregnant women. Thorax. 2010;65(8):739–44.

    Article  PubMed  Google Scholar 

  51. Sorri M, Hartikainen A, Karja I. Rhinitis during pregnancy. Rhinology. 1980;18(2):83–6.

    CAS  PubMed  Google Scholar 

  52. Munn M, Groome L, Atterbury J. Pneumonia as a complication of pregnancy. J Matern Fetal Med. 1999;8:151–4.

    CAS  PubMed  Google Scholar 

  53. Namazy JA, et al. Antibiotics for respiratory infections during pregnancy: prevalence and risk factors. J Allergy Clin Immunol Pract. 2016;4(6):1256–1257 e2.

    Article  PubMed  Google Scholar 

  54. Schatz M, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997;100(3):301–6.

    Article  CAS  PubMed  Google Scholar 

  55. Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide. J Allergy Clin Immunol. 2003;111(4):736–42.

    Article  CAS  PubMed  Google Scholar 

  56. Bracken MB, et al. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol. 2003;102(4):739–52.

    PubMed  Google Scholar 

  57. Martel MJ, et al. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ. 2005;330(7485):230.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Kallen B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93(3):392–5.

    CAS  PubMed  Google Scholar 

  59. Bakhireva LN, et al. Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol. 2005;116(3):503–9.

    Article  CAS  PubMed  Google Scholar 

  60. Breton MC, et al. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy. J Allergy Clin Immunol. 2010;126(4):772–777 e2.

    Article  CAS  PubMed  Google Scholar 

  61. Blais L, et al. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax. 2007;62(4):320–8.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Hyiid A, Molgaard-Nielesen D. Corticosteroid use during pregnancy and the risk of orofacial clefts. CMAJ. 2011;183:796–804.

    Article  Google Scholar 

  63. Kallen B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol. 2007;63(4):383–8.

    Article  PubMed  Google Scholar 

  64. Hyiid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and the risk of orofacial clefts. CMAJ. 2011;183:796–804.

    Article  Google Scholar 

  65. Blais L, et al. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol. 2009;124(6):1229–1234 e4.

    Article  CAS  PubMed  Google Scholar 

  66. Blais L, Forget A. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women. J Allergy Clin Immunol. 2008;121(6):1379–84, 1384.e1.

    Article  PubMed  Google Scholar 

  67. Cossette B, et al. Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax. 2013;68(8):724–30.

    Article  PubMed  Google Scholar 

  68. Murphy VE, et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG. 2013b;120(7):812–22.

    Article  CAS  PubMed  Google Scholar 

  69. Wang G, et al. The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;27(9):934–42.

    Article  PubMed  Google Scholar 

  70. de Aguiar MM, et al. Inhaled beclomethasone in pregnant asthmatic women – a systematic review. Allergol Immunopathol (Madr). 2013;42(5):493–9.

    Article  Google Scholar 

  71. Cossette B, et al. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Ann Allergy Asthma Immunol. 2014;112(5):459–64.

    Article  CAS  PubMed  Google Scholar 

  72. Charlton RA, et al. Safety of fluticasone propionate prescribed for asthma during pregnancy: a UK population-based cohort study. J Allergy Clin Immunol Pract. 2015;3(5):772–9.e3.

    Article  PubMed  Google Scholar 

  73. Lin S, et al. Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol. 2008;168:73–9.

    Article  PubMed  Google Scholar 

  74. Lin S, Herdt-Losavio M, Gensburg L, et al. Maternal asthma medication use and the risk of congenital heart defects. Birth Defects Res (Part A). 2009a;85:161–8.

    Article  CAS  Google Scholar 

  75. Lin S, et al. Maternal asthma, asthma medication use, and the risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol. 2009b;85(2):161–8.

    Article  CAS  PubMed  Google Scholar 

  76. Lin S, et al. Maternal asthma medication use and the risk of selected birth defects. Pediatrics. 2012;129:e317–24.

    Article  PubMed  Google Scholar 

  77. Busse ww. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol. 2005;115(1):34–46.

    Article  Google Scholar 

  78. Schaible AM, et al. High capacity for leukotriene biosynthesis in peripheral blood during pregnancy. Prostaglandins Leukot Essent Fatty Acids. 2013;89(4):245–55.

    Article  CAS  PubMed  Google Scholar 

  79. Sarkar M, et al. Montelukast use during pregnancy; a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol. 2009;65(12):1259–64.

    Article  CAS  PubMed  Google Scholar 

  80. Nelsen LM, et al. Congenital malformationsamong infants born to women receiving montelukast, inhlaed corticosteroids, and other asthma medications. J Allergy Clin Immunol. 2012;129(1):251–254.e6.

    Article  CAS  PubMed  Google Scholar 

  81. Dombrowski MP, et al. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol. 2004;190(3):737–44.

    Article  CAS  PubMed  Google Scholar 

  82. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiologic studies. Teratology. 2000;62:385–92.

    Article  CAS  PubMed  Google Scholar 

  83. Skuladottir H, et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100(6):499–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Namazy J, et al. Effects of asthma severity,exacerbations and oral corticosteroids on perinatal outcomes. Eur Respir J. 2012;41(5):1082–90.

    Article  PubMed  CAS  Google Scholar 

  85. Namazy J, et al. The Xolair pregnancy registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol. 2015;135(2):407–12.

    Article  CAS  PubMed  Google Scholar 

  86. Bandoli G, et al. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin N Am. 2017;43(3):489–502.

    Article  Google Scholar 

  87. Namazy J, et al. Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth. J Allergy Clin Immunol. 2004;113(3):427–32.

    Article  CAS  PubMed  Google Scholar 

  88. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review. Hum Exp Toxicol. 2006;25(8):447–52.

    Article  CAS  PubMed  Google Scholar 

  89. Wilson J. Use of sodium cromoglycate during pregnancy: results on 296 asthmatic women. Acta Therap. 1982;8(Suppl):45–51.

    Google Scholar 

  90. Tata LJ, et al. A comprehensive analysis of adverse obstetric and pediatric complications in women with asthma. Am J Respir Crit Care Med. 2007;175(10):991–7.

    Article  PubMed  Google Scholar 

  91. Bakhireva LN, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol. 2007;119(3):618–25.

    Article  CAS  PubMed  Google Scholar 

  92. Cavero-Carbonell C, et al. Fetal exposure to Montelukast and congenital anomalies: a population based study in Denmark. Birth Defects Res. 2017;109(6):452–9.

    Article  CAS  PubMed  Google Scholar 

  93. Briggs GG, et al. Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017. xiii, 1646 pp.

    Google Scholar 

  94. Munsie JW, et al. Maternal bronchodilator use and the risk of orofacial clefts. Hum Reprod. 2011;26(11):3147–54.

    Article  CAS  PubMed  Google Scholar 

  95. Garne E, et al. Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study. J Allergy Clin Immunol. 2015;136(6):1496–1502 e7.

    Article  PubMed  Google Scholar 

  96. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton: Publishing Sciences Group; 1977. xi, 516 p.

    Google Scholar 

  97. Wilton LV, et al. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol. 1998;105(8):882–9.

    Article  CAS  PubMed  Google Scholar 

  98. Eltonsy S, et al. Risk of congenital malformations for asthmatic pregnant women using a long-acting beta(2)-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. J Allergy Clin Immunol. 2015;135(1):123–30.

    Article  CAS  PubMed  Google Scholar 

  99. Stenius-Aarniala B, Riikonen S, Teramo K. Slow-release theophylline in pregnant asthmatics. Chest. 1995;107(3):642–7.

    Article  CAS  PubMed  Google Scholar 

  100. Park JM, Schmer V, Myers TL. Cardiovascular anomalies associated with prenatal exposure to theophylline. South Med J. 1990;83(12):1487–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Allergy and Immunology, Scripps Clinic, San Diego, CA, USA

    Jennifer A. Namazy

  2. Department of Allergy, Kaiser Permanente Medical Center, San Diego, CA, USA

    Michael Schatz

  3. Division of Pediatric Pulmonary Medicine, Golisano Children’s Hospital at Strong, University of Rochester Medical Center, Rochester, NY, USA

    Augusto A. Litonjua

Authors
  1. Jennifer A. Namazy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Schatz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Augusto A. Litonjua
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Augusto A. Litonjua .

Editor information

Editors and Affiliations

  1. Mary Parkes Center for Asthma, Allergy & Pulmonary Care, University of Rochester School of Medicine, Rochester, NY, USA

    Sandhya Khurana

  2. Asthma Clinical & Research Programs Pulmonary Sciences and Critical Care, University of Colorado, Denver, CO, USA

    Fernando Holguin

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Namazy, J.A., Schatz, M., Litonjua, A.A. (2020). Severe Asthma in Pregnancy: Special Considerations. In: Khurana, S., Holguin, F. (eds) Difficult To Treat Asthma. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-20812-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-20812-7_13

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-20811-0

  • Online ISBN: 978-3-030-20812-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation